Green B D, Battisti L, Koehler T M, Thorne C B, Ivins B E
Infect Immun. 1985 Aug;49(2):291-7. doi: 10.1128/iai.49.2.291-297.1985.
Virulent and certain avirulent strains of Bacillus anthracis harbor a plasmid, designated pXO2, which is involved in the synthesis of capsules. Two classes of rough, noncapsulated (Cap-) variants were isolated from the capsule-producing (Cap+) Pasteur vaccine strains ATCC 6602 and ATCC 4229. One class was cured of pXO2, and the other class still carried it. Reversion to Cap+ was demonstrable only in rough variants which had retained pXO2. Proof that pXO2 is involved in capsule synthesis came from experiments in which the plasmid was transferred by CP-51-mediated transduction and by a mating system in which plasmid transfer is mediated by a Bacillus thuringiensis fertility plasmid, pXO12. Cells of Bacillus cereus and a previously noncapsulated (pXO2-) strain of B. anthracis produced capsules after the acquisition of pXO2.
炭疽芽孢杆菌的强毒株和某些无毒株携带一种名为pXO2的质粒,该质粒参与荚膜的合成。从产荚膜(Cap+)的巴斯德疫苗株ATCC 6602和ATCC 4229中分离出两类粗糙的、无荚膜(Cap-)变体。一类变体失去了pXO2,另一类仍携带该质粒。只有在保留了pXO2的粗糙变体中才能观察到向Cap+的回复突变。pXO2参与荚膜合成的证据来自以下实验:通过CP-51介导的转导以及由苏云金芽孢杆菌育性质粒pXO12介导质粒转移的交配系统来转移该质粒。蜡样芽孢杆菌细胞和一株先前无荚膜(pXO2-)的炭疽芽孢杆菌菌株在获得pXO2后产生了荚膜。